Filter posts

BIO CEO & Investor Conference Succeeds in Bringing Innovators to Investors and Vice Versa

The 19th Annual BIO CEO & Investor Conference came to a close February 14, having …

Beyond the IPO: Reverse Mergers to Tap Public Market Capital

On the opening day of the 2017 BIO CEO & Investor Conference in New York …

Good Public Policy Key to Stable Biotech Investment Climate

It is an important and exciting time for the biotechnology industry. Science is galloping forward …

Curing Cancer: Advancements and What is Yet to Come

  Last month, MIT Technology Review reported “Two Infants Treated with Universal Immune Cells Have …

Best Practices for Communication Between FDA and IND Sponsors During Drug Development

The FDA recently released an online course to provide insights to drug sponsors on communicating …

2017 And Beyond: Experts Weigh In On GMOs & What Lies Ahead

The dawn of a new year is both a time for reflection and for excitement. …

Vaccine-Preventable Outbreaks on the Rise

Since the fall of 2008, the Council on Foreign Relations has been tracking outbreaks of …

Jim Greenwood in The Hill: Congress Needs to Prepare for the Next Pandemic

Europe, Asia, and South Korea have all recently reported rapid outbreaks of Bird Flu. With …

2016 Snapshot: BIO’s Top Five Health Blogs

There was no shortage of health hot topics this year, but as 2016 comes to …

PODCAST: Adult Vaccination Importance

Last week, The NACCHO Podcast Series hosted the Adult Vaccine Access Coalition (AVAC) to discuss …